Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Collagen based wound sealant

28.07.2003



A collagen-based wound sealant recently developed at Texas A&M University could be an alternative for human and animal wound care treatment.

The material – which can be poured or injected into the wound – speeds the closure of wounds, said Dr. Douglas Miller, research scientist with the Texas Agricultural Experiment Station and one of the scientists working on the project.

In testing, Miller and his colleagues found a significant difference in closure between treated and untreated wounds in laboratory rats. The treated wounds had the same amount of healing in three days as the controls in six days, thus speeding the closure of the wound by about 50 percent.



In other words, "The size of the wound shrank more rapidly when treated with the sealant," he said.

Normally minor soft tissue wounds can repair themselves with minimal treatment, he said. However, diabetic ulcers or sores that heal slowly are another story.

Over human history, thousands of preparations and treatments have been developed to assist in wound repair, he explained. Collagen itself has long been considered a favorite material for wound treatment because it is inexpensive, easily prepared and can be readily shaped to fit the wound site, Miller said. As a natural part of the body, it also causes few allergic reactions.

"Collagen is the most abundant protein in the mammalian body, and in skin, it’s about 60 percent of your total protein," he said.

"It’s been described as literally the glue that holds you together. The bottom line is that collagen has been used for centuries as something to repair wounds because it is a natural component of the tissue."

But collagen treatments alone "don’t bind the wound," Miller said.

Miller and the other researchers developed a matrix – or mixture – of collagen and other ingredients, as well as a polymerization (chemical) process that helps bind the sealant to the wound. The material, in texture, resembles gelatin but is flexible. Gelatin, on the other hand, is brittle and tears easily.

"If you’ve got a large, open wound, your body moves, your skin moves, your muscles flex, and if this doesn’t flex with it, it simply is going to tear. This has good mechanical strength, but it also has elasticity," he said.

Miller estimated the collagen-based sealant needs to be applied only once, therefore making it relatively inexpensive compared to other treatments.

About 10 ml – enough to fill a wound a little more than 1 inch in diameter and ½ inch deep – could be made for less than $100, he said. Even if a production as a medical grade material increases the cost, it still would be cheaper than repeated visits to the physician’s office to keep getting the wound cleaned, treated and re-bandaged several times a week, Miller said.

"One dose of this could replace all of that, and all you have to do is change the covering a couple of times a week," he said.

Miller also believes other healing promoters – such as slow-release antibiotics – could be added to the sealant. Basic Fibroblast growth factor, a protein which stimulates the growth of new connective tissue and blood vessels, already has been tested and found to further increase the rate of wound closure in 1-year-old rats.

He hopes further animal and human studies can begin soon.

"We cannot claim it increases the incidence of healing. That has not been tested yet. We observed that it seems to have decreased the visibility of scars, but we didn’t test that either."

Additional uses for this material might include a slow release depot for vaccines, adjuvants or drugs; bone repair; or graft or prosthetic implant stabilization.

"This product would have a potential widespread market throughout veterinary medical, and human medical and dental practice," he said.

Edith A. Chenault | Texas A&M University
Further information:
http://www.tamu.edu

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>